Retail investors showed caution, reducing their stock holdings in most companies during the March quarter. This move coincided with market declines due to global uncertainties. Meanwhile, foreign investors and domestic funds increased their stakes in various companies. Promoters also raised their shareholding, taking advantage of lower stock prices. FPI stake in Indian companies continued to fall.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026